Compare Grown Rogue International, Inc. with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
CAD 150 Million (Small Cap)
94.00
NA
0.00%
0.01
6.83%
6.38
Revenue and Profits:
Net Sales:
13 Million
(Quarterly Results - Mar 2026)
Net Profit:
-3 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
34.83%
0%
34.83%
6 Months
17.65%
0%
17.65%
1 Year
21.21%
0%
21.21%
2 Years
-34.78%
0%
-34.78%
3 Years
215.79%
0%
215.79%
4 Years
531.58%
0%
531.58%
5 Years
207.69%
0%
207.69%
Grown Rogue International, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
53.41%
EBIT Growth (5y)
15.77%
EBIT to Interest (avg)
-0.74
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
1.25
Tax Ratio
45.66%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.08%
ROCE (avg)
4.48%
ROE (avg)
0.57%
Valuation key factors
Factor
Value
P/E Ratio
94
Industry P/E
Price to Book Value
6.38
EV to EBIT
150.11
EV to EBITDA
37.42
EV to Capital Employed
6.35
EV to Sales
3.15
PEG Ratio
0.84
Dividend Yield
NA
ROCE (Latest)
0.99%
ROE (Latest)
6.83%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 2 Foreign Institutions (0.08%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
12.60
10.30
22.33%
Operating Profit (PBDIT) excl Other Income
1.40
-0.40
450.00%
Interest
0.80
0.40
100.00%
Exceptional Items
-1.90
2.40
-179.17%
Consolidate Net Profit
-3.00
1.10
-372.73%
Operating Profit Margin (Excl OI)
10.90%
-99.20%
11.01%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is 22.33% vs 14.44% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is -372.73% vs 118.33% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
45.30
36.50
24.11%
Operating Profit (PBDIT) excl Other Income
3.10
2.00
55.00%
Interest
1.90
2.60
-26.92%
Exceptional Items
0.40
-6.40
106.25%
Consolidate Net Profit
4.50
-21.90
120.55%
Operating Profit Margin (Excl OI)
-18.30%
2.30%
-2.06%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
About Grown Rogue International, Inc. 
Grown Rogue International, Inc.
Pharmaceuticals & Biotechnology
Grown Rogue International Inc, formerly Novicius Corp, is a Canada-based company engaged in the alternative medicine sector. The Company is a vertically-integrated cannabis brand that produces and distributes cannabis products. Grown Rogue International Inc specializes in seed-to-experience products through its indoor and outdoor facilities of more than 80,000 square feet, based in Rogue Valley of Southern Oregon, the United States. The Company’s brand offers: Flower, which comes in bags of different sizes together with matchboxes and rolling papers; Pre-rolls, which are nitrogen sealed; Cartridges, as well as Extracts including shatter, wax, oil and sugar that feature concentrated amounts of compounds like tetrahydrocannabinol (THC) and select terpenes.
Company Coordinates 
Company Details
1 King St W Suite 1505 , TORONTO ON : M5H 1A1
Registrar Details






